Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Apollo to buy LifePoint in latest private equity bet on healthcare

Published 23/07/2018, 17:17
© Reuters.  Apollo to buy LifePoint in latest private equity bet on healthcare
C
-
BARC
-
CSGN
-
LPNT
-
APO
-
KKR
-

By Tamara Mathias

(Reuters) - Apollo Global Management (N:APO) will buy LifePoint Health (O:LPNT) in a $5.6 billion (4.27 billion pounds) deal that will expand its rural U.S. hospitals business, the latest in a series of bets by private equity firms on healthcare.

The deal comes as Tennessee-based LifePoint and many of its peers face higher medical costs, fewer patient admissions and changes to reimbursement policies in Medicare and Medicaid that have pressured profits.

To compensate, LifePoint has been beefing up its presence in rural regions including in Pennsylvania and Tennessee, and streamlining operations at healthcare facilities there.

The deal will bring together LifePoint and Apollo's RCCH HealthCare Partners, LifePoint said in a statement, confirming a Reuters report on Friday that the parties were in advanced talks for a buyout.

Apollo's deal - its biggest this year - is the latest in a recent surge of public investments by U.S. private equity, the highest since the 2007-08 global financial crisis.

With a record $1 trillion in cash at their disposal, top private equity names have turned to healthcare. Just last month, KKR (N:KKR) and Veritas Capital each snapped up publicly-listed healthcare firms in multi-billion dollar deals.

Indeed, hospital operators are alluring to investors, Cantor Fitzgerald analyst Joseph France said. Because their operations are largely U.S.-based, hospital firms benefit more from lower tax rates than the average U.S. company, and are also more insulated from global trade uncertainties, France said.

Apollo's transaction value includes $2.9 billion of LifePoint's net debt and minority interest. The combined company will be led by current LifePoint Chief Executive Officer William Carpenter III.

LifePoint shares — down some 27 percent in the past year — jumped nearly 34 percent to $64 in premarket trading, $1 shy of Apollo's all-cash offer price.

Barclays (LON:BARC), Citigroup (NYSE:C), RBC Capital Markets and Credit Suisse (SIX:CSGN) will finance Apollo's acquisition. PSP Investments Credit USA LLC and an affiliate of Qatar Investment Authority will also provide part of the debt financing.

LifePoint will accept competing bids until Aug. 22, it said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.